1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


I trained in haematology and general medicine in Belfast and then in the Royal Postgraduate Medical school, Hammersmith Hospital. I was appointed senior lecturer in 1991 and have been an active researcher and clinician in haematological malignancy in Belfast since that time.


Key Words
Myeloproliferative Disorders, Polycythaemia Vera, Idiopathic Erythrocytosis, Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia and Clinical Trials.

I have received funding for Clinical Training Fellows from the Medical Research Council, Leukaemia Research Fund and the Research and Development Office Northern Ireland.

Research Statement

My main research interests are in myeloproliferative disorders, acute myeloid leukaemia and chronic myeloid leukaemia. I have an active clinical practice and collaborate with scientists looking at the pathogenesis of the myeloproliferative disorders and in particular investigations of patients with idiopathic erythrocytosis. I also work on the pathogenesis and treatment of Acute Myeloid Leukaemia and Chronic Myeloid Leukaemia.

Clinical Trials
With the clinical trials unit we have a number of phase three and phase two trials in the areas of acute myeloid leukaemia and chronic myeloid leukaemia and myeloproliferative disorders. We continually investigate for new and improved treatments in these disorders.

Fingerprint Dive into the research topics where Mary Frances McMullin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Aetiology of Myeloproliferative Neoplasms

McMullin, M. F. & Anderson, L. A., 06 Jul 2020, In : Cancers. 12, 7

Research output: Contribution to journalReview article

Open Access
  • 4 Downloads (Pure)

    Modifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms

    Duncombe, A. S., Anderson, L., James, G., De Vocht, F., Fritschi, L., Mesa, R., Clarke, M. & McMullin, M., 01 Feb 2020, In : HemaSphere. 4, 1, 6 p., 0327.

    Research output: Contribution to journalArticle

    Open Access
  • 34 Downloads (Pure)

    Ruxolitinib: gaining more than intended

    Greenfield, G. & McMullin, M. F., 26 Mar 2020, In : Blood. 135, 13, p. 983-984 2 p.

    Research output: Contribution to journalComment/debate

  • Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

    Rambaldi, A., Iurlo, A., Vannucchi, A. M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M. F., Cambier, N., Marolleau, J-P., Mesa, R. A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica, P., Manzoni, S. & 1 others, Di Tollo, S., 11 Feb 2020, In : Leukemia.

    Research output: Contribution to journalArticle

    Open Access
    2 Citations (Scopus)
    28 Downloads (Pure)

    A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The Elderly

    Daly, A. B., Cuthbert, R., Finnegan, D., Arnold, C., Craddock, C. & McMullin, M. F., Jan 2019, In : The Ulster Medical Journal. 88, 1, p. 25-29 5 p.

    Research output: Contribution to journalArticle

    Open Access
  • 28 Downloads (Pure)


    • 1 Publication peer-review


    Mary Frances McMullin (Associate editor)

    01 Jan 2008

    Activity: Publication peer-review and editorial work typesPublication peer-review


    Identifying Patients with Rare Forms of Erythrocytosis

    Mary Frances McMullin (Participant), Terence Lappin (Participant) & Anne Hughes (Participant)

    Impact: Health Impact, Quality of Life Impact